BC
BCYC
BICYCLE THERAPEUTICS PLC
$4.40
-0.45%
$308.6M
No data for this timeframe.
Vol
Market Cap$308.6M
Cap SizeSmall Cap
Analyst ConsensusBuy (68%)
Inst. Holders6 funds
Inst. Value$8.9M
Inst. Activity0 buys / 3 sells
Insider Activity0B / 10S
Insider Net $-$68.3K
SEC Reports1
Recent Activity
Apr 29, 2026
earnings_calendar
BCYC Q1 2026 Earnings Scheduled — 2026-04-29
Apr 20, 2026
SEC
Bicycle Therapeutics announced positive Phase 1/2 clinical data for its nuzefatide pevedotin in combination with nivolum
8-K — Impact 7/10
Apr 6, 2026
Insider
Skynner Michael sold 525 shares
CHIEF SCIENTIFIC OFFICER @ $5.05 ($2.7K)
Apr 6, 2026
Insider
Perry Jennifer Scott sold 37 shares
Chief Operating Officer @ $5.05 ($186.85)
Apr 6, 2026
Insider
Lee Kevin sold 1,716 shares
CHIEF EXECUTIVE OFFICER @ $5.05 ($8.7K)
Inst.
MORGAN STANLEY — TRIM
465,222 shares ($3.3M)
Inst.
TWO SIGMA INVESTMENTS, LP — TRIM
132,032 shares ($934.8K)
Price Targets
$12.11
+175.3% upside
Strong Buy
Current $4.40
Low $5.00
Median $8.00
High $36.00
9 analysts
$5.00
$36.00
Analyst Ratings
6Strong Buy
7Buy
6Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Apr 8, 2026 | Morgan Stanley | MAINTAIN | Equal-Weight → Equal-Weight |
| Mar 18, 2026 | Oppenheimer | MAINTAIN | Outperform → Outperform |
| Mar 18, 2026 | RBC Capital | MAINTAIN | Sector Perform → Sector Perform |
| Mar 18, 2026 | Citizens | MAINTAIN | Market Outperform → Market Outperform |
| Mar 18, 2026 | Needham | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.58 ▼ -0.9% | $-0.75 — $-0.37 | 49% YoY | 10 |
| Next Q | $-0.50 ▼ -1.8% | $-0.66 — $-0.29 | 41% YoY | 10 |
| Current FY | $-2.31 ▼ -11.3% | $-2.86 — $-1.30 | 27% YoY | 11 |
| Next FY | $-2.13 ▼ -12.4% | $-2.56 — $-1.32 | 7% YoY | 10 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $4.0M | ADD |
| MORGAN STANLEY | $3.3M | TRIM |
| TWO SIGMA INVESTMENTS, LP | $934.8K | TRIM |
| BANK OF AMERICA CORP | $682.5K | NEAR_EXIT |
| FMR LLC | $2.2K | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 6, 2026 | Skynner Michael | SELL | $2.7K |
| Apr 6, 2026 | Perry Jennifer | SELL | $186.85 |
| Apr 6, 2026 | Lee Kevin | SELL | $8.7K |
| Apr 6, 2026 | Thompson Travis | SELL | $515.10 |
| Apr 6, 2026 | Hannay Michael | SELL | $1.3K |
6 institutional holders with $8.9M total value (1,260,771 shares) as of 2025-Q4. Top holders: RENAISSANCE, MORGAN, TWO. Net selling activity: 3 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | 566,600 | $4.0M | 44.9% | ADD +62.9% |
| 2 | MORGAN STANLEY | 465,222 | $3.3M | 36.9% | TRIM -43.5% |
| 3 | TWO SIGMA INVESTMENTS, LP | 132,032 | $934.8K | 10.5% | TRIM -28.5% |
| 4 | BANK OF AMERICA CORP /DE/ | 96,401 | $682.5K | 7.6% | NEAR_EXIT -83.7% |
| 5 | FMR LLC | 316 | $2.2K | 0.0% | — |
| 6 | WELLS FARGO & COMPANY/MN | 200 | $1.4K | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | TRIM | 822,705 | 465,222 | -43.5% | $3.3M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 184,537 | 132,032 | -28.5% | $934.8K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | 591,535 | 96,401 | -83.7% | $682.5K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 830,634 | 591,535 | -28.8% | $4.6M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 318,400 | 518,700 | +62.9% | $4.0M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 56,198 | 184,537 | +228.4% | $1.4M | 2025-Q3 |
| UBS Group AG | TRIM | 33,375 | 11,373 | -65.9% | $88.0K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | ADD | 563,559 | 830,634 | +47.4% | $5.8M | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 56,198 | — | $390.6K | 2025-Q2 |
| UBS Group AG | TRIM | 72,702 | 33,375 | -54.1% | $232.0K | 2025-Q2 |
| UBS Group AG | TRIM | 132,361 | 72,702 | -45.1% | $617.2K | 2025-Q1 |
| MORGAN STANLEY | TRIM | 1,349,894 | 862,137 | -36.1% | $12.1M | 2024-Q4 |
| CITADEL ADVISORS LLC | ADD | 120,449 | 154,930 | +28.6% | $2.2M | 2024-Q4 |
| UBS Group AG | DOUBLED | 12,066 | 132,361 | +997.0% | $1.9M | 2024-Q4 |
5 unique insiders with 10 transactions. Net insider value: -$68.3K ($0.00 bought, $68.3K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 6, 2026 | Skynner Michael | CHIEF SCIENTIFIC OFFICER | SELL | 525 | $5.05 | $2.7K |
| Apr 6, 2026 | Perry Jennifer Scott | Chief Operating Officer | SELL | 37 | $5.05 | $186.85 |
| Apr 6, 2026 | Lee Kevin | CHIEF EXECUTIVE OFFICER | SELL | 1,716 | $5.05 | $8.7K |
| Apr 6, 2026 | Thompson Travis Alvin | Chief Financial Officer | SELL | 102 | $5.05 | $515.10 |
| Apr 6, 2026 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | SELL | 251 | $5.05 | $1.3K |
| Apr 2, 2026 | Lee Kevin | CHIEF EXECUTIVE OFFICER | SELL | 5,967 | $4.91 | $29.3K |
| Apr 2, 2026 | Skynner Michael | CHIEF SCIENTIFIC OFFICER | SELL | 1,879 | $4.91 | $9.2K |
| Apr 2, 2026 | Perry Jennifer Scott | Chief Operating Officer | SELL | 1,038 | $4.91 | $5.1K |
| Apr 2, 2026 | Thompson Travis Alvin | Chief Financial Officer | SELL | 799 | $4.91 | $3.9K |
| Apr 2, 2026 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | SELL | 1,521 | $4.91 | $7.5K |
| Feb 3, 2026 | Thompson Travis Alvin | Chief Financial Officer | A | 58,000 | $0.00 | $0.00 |
1 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 0 neutral. Avg impact: 7.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Buy (68% buy). Based on 19 analysts: 6 strong buy, 7 buy, 6 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$12.11 mean target
+175.3% upside
Strong Buy (1.91)
$5.00 Low
$36.00 High
| Metric | Value |
|---|---|
| Current Price | $4.40 |
| Target Low | $5.00 |
| Target Mean | $12.11 |
| Target Median | $8.00 |
| Target High | $36.00 |
| # Analysts | 9 |
| Recommendation | Strong Buy (1.91) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.58 | $-0.75 | $-0.37 | 49.5% | -0.9% | 1↑ 1↓ | $0.0B | 48.8% | 10 |
| Next Q 2026-09-30 |
$-0.50 | $-0.66 | $-0.29 | 41.3% | -1.8% | 1↑ 1↓ | $0.0B | -63.8% | 10 |
| Current FY 2026-12-31 |
$-2.31 | $-2.86 | $-1.30 | 27.0% | -11.3% | 1↑ 8↓ | $0.0B | -76.0% | 11 |
| Next FY 2027-12-31 |
$-2.13 | $-2.56 | $-1.32 | 7.5% | -12.4% | 2↑ 2↓ | $0.0B | -24.4% | 10 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.576 | |
| 7d ago | $-0.599 | +0.023 |
| 30d ago | $-0.571 | -0.005 |
| 60d ago | $-0.994 | +0.418 |
| 90d ago | $-0.994 | +0.418 |
6 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Apr 8, 2026 | Morgan Stanley | MAINTAIN | Equal-Weight | Equal-Weight |
| Mar 18, 2026 | Oppenheimer | MAINTAIN | Outperform | Outperform |
| Mar 18, 2026 | RBC Capital | MAINTAIN | Sector Perform | Sector Perform |
| Mar 18, 2026 | Citizens | MAINTAIN | Market Outperform | Market Outperform |
| Mar 18, 2026 | Needham | MAINTAIN | Buy | Buy |
| Nov 24, 2025 | Truist Securities | INITIATE | — | Hold |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 6 | 7 | 6 | 0 | 0 | 68% | |
| Apr 1, 2026 | 6 | 7 | 6 | 0 | 0 | 68% | |
| Mar 1, 2026 | 6 | 8 | 6 | 0 | 0 | 70% | |
| Feb 1, 2026 | 6 | 8 | 6 | 0 | 0 | 70% | |
| Jan 1, 2026 | 6 | 8 | 6 | 0 | 0 | 70% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Apr 29, 2026
earnings_calendar
BCYC Q1 2026 Earnings Scheduled — 2026-04-29
Feb 23, 2026
earnings_calendar
BCYC Q4 2025 Earnings After Market Close — 2026-02-23